Inflation Drives Up Cost of EU Inspections
This article was originally published in The Gold Sheet
Effective immediately, the European Commission March 27 increased the rate it charges for inspections to 18,200 Euros, or nearly $28,600 at the current exchange rate. Applicants for EU marketing authorization must pay the fee to the scientific committee that requested the inspection - either the one for human drugs or the one for veterinary drugs. The committees request pre-approval inspections and also can request post-authorization inspections. For inspections of facilities outside the European Community, the applicant also must pay travel expenses
You may also be interested in...
If President Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsberg, Affordable Care Act coverage could disappear. See what Kyle Sampson, a partner with the Washington, DC law firm King & Spalding said about it here.
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.